The ”la Caixa” Foundation strengthens its role as one of the major drivers of biomedical research in Europe with the launch of the CaixaResearch Institute, a project that synthesizes over 120 years of commitment to health, science, and talent. From its origin in 1904, promoted by Francesc Moragas, to the present day under the presidency of Isidro Fainé, the entity has maintained a social vocation aimed at improving quality of life, with special attention to the most vulnerable groups.
Read more Workers from two institutes in l’Hospitalet protest against the presence of mossos in the centers
Throughout its history, the Foundation has promoted pioneering initiatives in the health sector, from visual impairment care centers to the fight against diseases such as tuberculosis. Over time, it expanded its action with scholarship programs that have fostered the talent of thousands of students. From the nineties onwards, it strengthened its commitment to research with the creation and support of centers such as IrsiCaixa, as well as collaborations with ISGlobal, Vall d’Hebron Institute of Oncology (VHIO), and BarcelonaBeta Brain Research Center.

Today, with increasing investment –the Research and Scholarships area already represents 20% of its budget–, the Foundation positions CaixaResearch Institute as the core of an ecosystem oriented towards innovation, knowledge transfer, and the humanization of health.
A center to connect science
CaixaResearch Institute was created with the aim of overcoming the traditional fragmentation of biomedical research. Its commitment to immunology responds to its transversal nature, capable of connecting diseases and disciplines. “The idea was to create something that would generate synergies with what already existed,” explains Àngel Font, the institute’s executive director. “That’s why the focus on immunology, a transversal field connected to cancer, infections, neurodegeneration, and autoimmunity.” Advances in vaccines, immunotherapy, and neuroimmunology have opened new avenues for diagnosis and treatment. However, major challenges persist, such as understanding why immune responses vary between people or how they become dysregulated in certain diseases.
The Scientific Committee of the ”la Caixa” Foundation, chaired by Javier Solana, has played a strategic role in defining the vision of CaixaResearch Institute. In addition, the institute has its own Scientific Council, led by oncologist Josep Tabernero, which ensures its progress is aligned with international standards of scientific excellence in immunology.

The center structures its activity into three main areas: immunology and diseases, exposomic sciences –which analyze the impact of the environment on health– and systems immunology, supported by artificial intelligence and advanced technologies.
International reference talent
The institute brings together top-level researchers in different areas of immunology. Among them, Dr. Gabriel Rabinovich, biochemist and PhD in Immunology, senior leader at CaixaResearch Institute and co-founder of Galtec, focuses his work on galectins and their role in cancer and autoimmunity. Also part of the team is Dr. Josep Dalmau, neurologist specializing in neuro-oncology, PhD in Medicine and senior leader at CaixaResearch Institute, who investigates immune mechanisms in the nervous system. For her part, Dr. Maria Mittelbrunn, head of the Immunometabolism and Inflammation Laboratory at the Severo Ochoa Molecular Biology Center and future senior group leader at CRI, analyzes immunological aging.
The team is completed with profiles such as Dr. Gemma Moncunill, biologist and PhD in Immunology, consolidated group leader at CaixaResearch Institute and specialized in vaccines; Dr. Héctor Huerga Encabo, biologist specialized in biomedicine, PhD in Immunology and junior group leader at CaixaResearch Institute, who studies mutations associated with aging, and Dr. María Martínez López, biochemist, neuroimmunology researcher and junior group leader at CaixaResearch Institute, focused on the relationship between the immune system and the nervous system.

Architecture designed for science
The institute’s building, designed by TAC Arquitectes and led by Eduard Gascón, responds to the needs of advanced research. With an investment of 80 million euros and 20,000 m², the space is organized into modular units that foster collaboration.
Located between Collserola and the Ronda de Dalt, the center integrates sustainability criteria such as geothermal energy, solar energy, and water reuse, which helps reduce energy consumption and environmental impact. The project is part of a scientific campus connected to CosmoCaixa and the Francesc Moragas gardens. Inside, a sculpture by Richard Serra symbolizes the solidity and balance that characterize both architecture and scientific research.
CaixaResearch Institute is integrated into an ecosystem promoted by the ”la Caixa” Foundation which, with its incorporation, brings together seven biomedical research centers with complementary profiles, with the aim of connecting disciplines and accelerating translational research.
Read more Impasse on Everest: hundreds of mountaineers waiting for the serac to melt
In the field of infectious diseases, IrsiCaixa contributes decades of experience in the study of HIV and immune response. Its director, Dr. Bonaventura Clotet, emphasizes that “studying HIV allowed us to understand how the immune system works and its relationship with other diseases.”
In global health, ISGlobal contributes with its research on vaccines and infectious diseases. Dr. Quique Bassat highlights “the need to translate immunological advances into real tools to reduce health inequities.”

In oncology, VHIO has consolidated itself as a benchmark in personalized medicine. Its director, Dr. Tabernero, reminds us that “science is entirely collaborative, and thinking otherwise is neither efficient nor fair.”
In the field of neurodegeneration, BarcelonaBeta Brain Research Center focuses its work on Alzheimer’s. Dr. Arcadi Navarro, director of the Alzheimer’s research center where the Pasqual Maragall Foundation carries out its activities, emphasizes “ensuring that research has a real impact on patients and the healthcare system.”

In pediatric research, Institut de Recerca Sant Joan de Déu contributes its specialization in childhood diseases. Its director, Dr. Joan Comella, emphasizes that joint work “allows advances to be translated into pediatric clinical practice.”
Finally, the Gulbenkian Institute for Molecular Medicine expands the network at a European scale with its focus on molecular medicine. Its director, Dr. Maria Mota, summarizes the shared vision: “The immune system is at the center of everything and connects multiple organs and systems.”
Philanthropy to boost European science
CaixaResearch Institute is part of an expanding model of scientific philanthropy in Europe. In recent meetings organized by the Philanthropy Europe Association (Philea), more than twenty foundations have agreed on the importance of creating centers with autonomy and a long-term vision. “These spaces strengthen European competitiveness,” states Àngel Font. Similarly, Danielle Kemmer, from the Novo Nordisk Foundation, points out that philanthropy allows “working with a long-term vision, independent of political cycles.”
Science with social impact
With the 2025-2030 Strategic Plan, the ”la Caixa” Foundation aims to consolidate a European biomedical research ecosystem, attract international talent, and generate knowledge with a direct impact on society.
The CaixaResearch Institute symbolizes this turning point: a space where science, collaboration, and philanthropy converge to accelerate innovation and improve people’s lives. A project that looks to the future without losing sight of the social commitment that has guided the entity for over a century.
Read more Nissan announces an ERE for three centers in Catalonia and deepens its industrial exit